ATE158291T1 - Pharmazeutische verbindungen - Google Patents

Pharmazeutische verbindungen

Info

Publication number: ATE158291T1
Authority: AT; Austria
Prior art keywords: alkyl; optionally substituted; hydroxy; triazolyl; phenyl
Prior art date: 1993-03-24

Application number

AT94302040T

Other languages

English (en)

Inventor

Andrew Caerwyn Williams

Original Assignee

Lilly Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-03-24

Filing date

1994-03-22

Publication date

1997-10-15

1994-03-22 Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd

1997-10-15 Application granted granted Critical

1997-10-15 Publication of ATE158291T1 publication Critical patent/ATE158291T1/de

Links

150000001875 compounds Chemical class 0.000 title abstract 2
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 11
-1 1-imidazolyl Chemical group 0.000 abstract 5
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 5
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 4
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 3
125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 abstract 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
125000004185 ester group Chemical group 0.000 abstract 2
125000001072 heteroaryl group Chemical group 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 2
125000001624 naphthyl group Chemical group 0.000 abstract 2
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 2
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
125000004414 alkyl thio group Chemical group 0.000 abstract 1
125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
125000002541 furyl group Chemical group 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
150000002825 nitriles Chemical class 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000005010 perfluoroalkyl group Chemical group 0.000 abstract 1
125000004076 pyridyl group Chemical group 0.000 abstract 1
125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000001544 thienyl group Chemical group 0.000 abstract 1
125000001425 triazolyl group Chemical group 0.000 abstract 1
125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyrane Compounds (AREA)

AT94302040T 1993-03-24 1994-03-22 Pharmazeutische verbindungen ATE158291T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB939306062A GB9306062D0 (en)	1993-03-24	1993-03-24	Pharmaceutical compounds

Publications (1)

Publication Number	Publication Date
ATE158291T1 true ATE158291T1 (de)	1997-10-15

Family

ID=10732627

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94302040T ATE158291T1 (de)	1993-03-24	1994-03-22	Pharmazeutische verbindungen

Country Status (10)

Country	Link
US (4)	US5514699A (de)
EP (1)	EP0618206B1 (de)
JP (1)	JPH072845A (de)
AT (1)	ATE158291T1 (de)
CA (1)	CA2119530A1 (de)
DE (1)	DE69405624T2 (de)
DK (1)	DK0618206T3 (de)
ES (1)	ES2107129T3 (de)
GB (1)	GB9306062D0 (de)
GR (1)	GR3025637T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0599514A3 (en) *	1992-11-18	1994-07-06	Lilly Industries Ltd	Pyranoquinoline derivatives as inhibitors of cell proliferation.
HRP960352A2 (en) *	1996-07-26	1998-08-31	Pliva Pharm & Chem Works	Novel coumarin quinoline carboxylic acids
AUPO227896A0 (en)	1996-09-13	1996-10-03	Fujisawa Pharmaceutical Co., Ltd.	Novel compounds and their preparation
DE60008574T2 (de) *	1999-11-05	2009-10-01	Cytovia, Inc., San Diego	Substituierte 4H-Chromene und Analoga als Caspase-Aktivatoren und Apoptose-Induktoren und deren Verwendung
WO2002092083A1 (en) *	2001-05-16	2002-11-21	Cytovia, Inc.	7,8-fused 4$i(h)-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
EP1392283A4 (de)	2001-05-16	2004-10-20	Cytovia Inc	Substituierte cumarine und chinoline als caspase-aktivatoren
US6858607B1 (en)	2001-05-16	2005-02-22	Cytovia, Inc.	7,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
JP4593880B2 (ja) *	2001-05-16	2010-12-08	サイトビアインコーポレイテッド	カスパーゼの活性化因子およびアポトーシスの誘導因子としての置換された４ｈ−クロメンおよび類似体、並びにその使用方法
CA2484702A1 (en) *	2002-05-16	2003-11-27	Cytovia, Inc.	Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
US7476741B2 (en)	2002-05-16	2009-01-13	Cytovia, Inc.	Substituted 4H-chromens, 2H-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof
CN103328463B (zh)	2010-11-12	2018-04-03	德国癌症研究中心	作为Wnt通路拮抗剂的色烯衍生物及其类似物
EP2776413A1 (de)	2011-11-10	2014-09-17	Memorial Sloan-Kettering Cancer Center	Behandlung von eierstockkrebs mit [2-amino-4h-naphtho-1,2-b-]pyran-3-carbonitrilen
KR102454815B1 (ko) *	2018-02-21	2022-10-17	삼성전자주식회사	브라켓과 용량성 결합을 형성하고, 상기 브라켓에 배치된 복수의 회로 기판들의 접지부들과 전기적으로 연결된 도전성 부재를 포함하는 전자 장치

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2631710B2 (ja) *	1988-08-16	1997-07-16	日本ヘキスト・マリオン・ルセル株式会社	ピラノ〔ｆ〕キノリノン誘導体及び該化合物を有効成分とする医薬組成物
CA2081577A1 (en) *	1990-06-20	1991-12-21	Ronald B. Gammill	Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1, 3-benzoxazine-4-ones
US5284868A (en) *	1991-10-09	1994-02-08	Eli Lilly And Company	Pharmaceutical compounds
GB9203497D0 (en) *	1992-02-19	1992-04-08	Lilly Industries Ltd	Pharmaceutical compounds
US5281619A (en) *	1992-09-25	1994-01-25	Eli Lilly And Company	Therapy for diabetic complications
EP0599514A3 (en) *	1992-11-18	1994-07-06	Lilly Industries Ltd	Pyranoquinoline derivatives as inhibitors of cell proliferation.

1993
- 1993-03-24 GB GB939306062A patent/GB9306062D0/en active Pending
1994
- 1994-03-21 US US08/215,344 patent/US5514699A/en not_active Expired - Fee Related
- 1994-03-21 CA CA002119530A patent/CA2119530A1/en not_active Abandoned
- 1994-03-22 EP EP94302040A patent/EP0618206B1/de not_active Expired - Lifetime
- 1994-03-22 DK DK94302040.4T patent/DK0618206T3/da active
- 1994-03-22 AT AT94302040T patent/ATE158291T1/de not_active IP Right Cessation
- 1994-03-22 DE DE69405624T patent/DE69405624T2/de not_active Expired - Fee Related
- 1994-03-22 ES ES94302040T patent/ES2107129T3/es not_active Expired - Lifetime
- 1994-03-23 JP JP6050918A patent/JPH072845A/ja active Pending
1995
- 1995-06-05 US US08/461,343 patent/US5571818A/en not_active Expired - Fee Related
- 1995-06-05 US US08/463,530 patent/US5576325A/en not_active Expired - Fee Related
- 1995-06-05 US US08/463,838 patent/US5574034A/en not_active Expired - Fee Related
1997
- 1997-12-10 GR GR970403289T patent/GR3025637T3/el unknown

Also Published As

Publication number	Publication date
US5571818A (en)	1996-11-05
ES2107129T3 (es)	1997-11-16
US5574034A (en)	1996-11-12
US5514699A (en)	1996-05-07
GR3025637T3 (en)	1998-03-31
EP0618206A1 (de)	1994-10-05
DE69405624T2 (de)	1998-01-15
CA2119530A1 (en)	1994-09-25
GB9306062D0 (en)	1993-05-12
JPH072845A (ja)	1995-01-06
DE69405624D1 (de)	1997-10-23
EP0618206B1 (de)	1997-09-17
US5576325A (en)	1996-11-19
DK0618206T3 (da)	1997-10-27

Legal Events

Date	Code	Title	Description
1998-04-15	UEP	Publication of translation of european patent specification
2003-12-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE158291T1 (de)	1997-10-15	Pharmazeutische verbindungen
FR16C1001I1 (fr)	2016-07-01	"Dérivé de 2-oxo-1-pyrrolidine et ses applications pharmaceutique"
EA199800290A1 (ru)	1998-10-29	(метилсульфонил) фенил-2-(5н)-фураноны в качестве ингибиторов циклооксигеназы-2
AU2621692A (en)	1993-04-22	4H-naphtho(1,2-b)pyran derivatives and their use as pharmaceuticals
ATE215371T1 (de)	2002-04-15	Naphthyl substituierte benzimidazolderivate als antikoagulantien
IL95675A0 (en)	1991-06-30	Pyrazole derivatives,processes for preparation thereof and pharmaceutical compositions containing the same
MY109777A (en)	1997-06-30	Pharmaceutical compounds therewith
ES2131294T3 (es)	1999-07-16	Compuestos herbicidas de pirrolo-piridina.
EP0546177A4 (de)	1993-04-16	Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält.
NO20023298D0 (no)	2002-07-08	Nye imidazolderivater
ES2196174T3 (es)	2003-12-16	`derivados de sesquiterpeno de actividad antiviral.
NZ275620A (en)	1999-01-28	3-optionally substituted phenyl or naphthyl-1,2,4-triazole derivatives; pharmaceutical compositions
JO1814B1 (en)	1995-07-05	Therapeutic agents
DK0600085T3 (de)	1997-07-07